# Study of Dosage Individualisation for the Treatment of Acute Myeloid Leukemia

> **NCT00969891** · — · COMPLETED · sponsor: **Mikkel Krogh-Madsen** · enrollment: 23 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **OTHER:** PK-PD analysis

## Key facts

- **NCT ID:** NCT00969891
- **Lead sponsor:** Mikkel Krogh-Madsen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** —
- **Final completion:** 2011-08
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2011-08-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00969891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00969891, "Study of Dosage Individualisation for the Treatment of Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00969891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*